What is she best known for?
The fields of study she is best known for:
- Enzyme
- Biochemistry
- Organic chemistry
Her scientific interests lie mostly in Biosensor, Chromatography, Analyte, Nanotechnology and Analytical chemistry.
Her studies deal with areas such as Silanes, Covalent bond, Sample preparation, Adsorption and Ricin as well as Biosensor.
Her Chromatography research includes elements of Immunoassay, Fluorescence, Antigen and Fiber.
Frances S. Ligler interconnects Fluidics, Porous membrane, Membrane, Biological system and Binding site in the investigation of issues within Analyte.
In Nanotechnology, Frances S. Ligler works on issues like Microfabrication, which are connected to Microfiber, Microscale chemistry, Nanofiber, Lithography and Hydrodynamic focusing.
Her studies in Analytical chemistry integrate themes in fields like Fluorescence spectroscopy, Ccd camera and Fluorophore.
Her most cited work include:
- Microneedle-array patches loaded with hypoxia-sensitive vesicles provide fast glucose-responsive insulin delivery (358 citations)
- Use of thiol-terminal silanes and heterobifunctional crosslinkers for immobilization of antibodies on silica surfaces. (343 citations)
- A microarray immunoassay for simultaneous detection of proteins and bacteria (298 citations)
What are the main themes of her work throughout her whole career to date?
The scientist’s investigation covers issues in Biosensor, Nanotechnology, Chromatography, Microfluidics and Analyte.
Her Biosensor research includes themes of Detection limit, Analytical chemistry, Fluorescence, Optoelectronics and Optical fiber.
Her study in Nanotechnology is interdisciplinary in nature, drawing from both Microfiber and Polymer.
Her study looks at the relationship between Chromatography and topics such as Antigen, which overlap with Antibody.
Her study in the field of Hydrodynamic focusing is also linked to topics like Communication channel.
Analyte and Fluidics are commonly linked in her work.
She most often published in these fields:
- Biosensor (39.09%)
- Nanotechnology (27.20%)
- Chromatography (22.66%)
What were the highlights of her more recent work (between 2014-2021)?
- Microfluidics (17.56%)
- Nanotechnology (27.20%)
- Biomedical engineering (6.80%)
In recent papers she was focusing on the following fields of study:
Frances S. Ligler mainly focuses on Microfluidics, Nanotechnology, Biomedical engineering, Drug delivery and Regenerative medicine.
Her Microfluidics study combines topics from a wide range of disciplines, such as Tissue engineering, Flow, Mechanics, Volumetric flow rate and Capillary action.
Her Nanotechnology research integrates issues from Cyclodextrin, Microscale chemistry and Microfabrication.
The Biomedical engineering study combines topics in areas such as Fiber, Burn wound, In vivo and Fibrin.
Her Drug delivery research is multidisciplinary, incorporating perspectives in Hypoxia, Nanomedicine and Photothermal therapy.
As a part of the same scientific study, Frances S. Ligler usually deals with the Hypoxia, concentrating on Pancreas and frequently concerns with Diabetes mellitus, Insulin and Vesicle.
Between 2014 and 2021, her most popular works were:
- Microneedle-array patches loaded with hypoxia-sensitive vesicles provide fast glucose-responsive insulin delivery (358 citations)
- Transformable liquid-metal nanomedicine (208 citations)
- Hypoxia and H2O2 Dual-Sensitive Vesicles for Enhanced Glucose-Responsive Insulin Delivery (119 citations)
In her most recent research, the most cited papers focused on:
- Enzyme
- Biochemistry
- Organic chemistry
Frances S. Ligler mainly investigates Nanotechnology, Microfluidics, Drug delivery, Angiogenesis and Cancer research.
When carried out as part of a general Nanotechnology research project, her work on Biosensor and Optical biosensor is frequently linked to work in Doxorubicin and Dynamic field, therefore connecting diverse disciplines of study.
Her Microfluidics study incorporates themes from Tissue engineering and Systems engineering.
The study incorporates disciplines such as Diabetes mellitus, Hypoxia and Nanomedicine in addition to Drug delivery.
Her biological study spans a wide range of topics, including Blood vessel, Stem cell, Myocardial infarction and Fibrin.
The various areas that Frances S. Ligler examines in her Cancer research study include Chimeric antigen receptor, Immunotherapy and Cell therapy.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
